Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-10

Clinical Trial Update: Mast Cells in Acid-induced Intestinal Permeability [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the role of mast cells in acid-induced intestinal permeability for dyspepsia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Dyspepsia | Phase 4 | Status: TERMINATED